avapro has been researched along with Hypertriglyceridemia in 3 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Hypertriglyceridemia: A condition of elevated levels of TRIGLYCERIDES in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, thirteen-week-old spontaneously hypertensive (SHR)/NDmcr-cp rats, representing a genetic model of metabolic syndrome, were treated daily with placebo, irbesartan (30 mg/kg), valsartan (10 mg/kg), or pioglitazone (10 mg/kg) for 4 weeks." | 3.77 | Irbesartan prevents metabolic syndrome in rats via activation of peroxisome proliferator-activated receptor γ. ( Jin, D; Miyazaki, M; Takai, S, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rong, X | 1 |
| Li, Y | 1 |
| Ebihara, K | 1 |
| Zhao, M | 1 |
| Kusakabe, T | 1 |
| Tomita, T | 1 |
| Murray, M | 1 |
| Nakao, K | 1 |
| Takai, S | 1 |
| Jin, D | 1 |
| Miyazaki, M | 1 |
| Ceriello, A | 1 |
| Assaloni, R | 1 |
| Da Ros, R | 1 |
| Maier, A | 1 |
| Piconi, L | 1 |
| Quagliaro, L | 1 |
| Esposito, K | 1 |
| Giugliano, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Relation Between Postprandial Lipogram and Coronary Artery Disease Severity[NCT03175393] | 100 participants (Anticipated) | Observational | 2017-07-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for avapro and Hypertriglyceridemia
| Article | Year |
|---|---|
Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients.
Topics: Anticholesteremic Agents; Atorvastatin; Biphenyl Compounds; Case-Control Studies; Diabetes Mellitus, | 2005 |
2 other studies available for avapro and Hypertriglyceridemia
| Article | Year |
|---|---|
Irbesartan treatment up-regulates hepatic expression of PPARalpha and its target genes in obese Koletsky (fa(k)/fa(k)) rats: a link to amelioration of hypertriglyceridaemia.
Topics: Animals; Biphenyl Compounds; Blotting, Western; Gene Expression; Hypertension; Hypertriglyceridemia; | 2010 |
Irbesartan prevents metabolic syndrome in rats via activation of peroxisome proliferator-activated receptor γ.
Topics: Adiponectin; Adipose Tissue; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Bip | 2011 |